Clinical Trials Logo

Appendiceal Neoplasms clinical trials

View clinical trials related to Appendiceal Neoplasms.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT05305820 Active, not recruiting - Ovarian Cancer Clinical Trials

Perioperative Exercise and Nutritional Optimisation Prehabilitation Before Surgery for Patients With Peritoneal Malignancy

PANO
Start date: September 1, 2022
Phase: N/A
Study type: Interventional

People who are diagnosed with cancer of the colon/rectum/appendix/ovaries that spreads into the lining of the tummy and some ovarian cancers or people with pseudomyxoma peritonei can often undergo intensive treatment including major surgery where chemotherapy is given whilst the person is having surgery - also known by doctors as surgery and hyperthermic intraperitoneal chemotherapy (HIPEC). Fitness for this surgery can improve if people undertake a prehabilitation programme at the time they get their diagnosis. To date, little research has focused on how exercise and nutrition support before surgery can help these patients during recovery. The aim of this study is to explore the use of exercise and nutritional support pre-treatment to enhance physical and psychological outcomes for patients.

NCT ID: NCT04902872 Active, not recruiting - Breast Cancer Clinical Trials

Study of CBX-12 in Subjects With Advanced or Metastatic Refractory Solid Tumors

Start date: May 3, 2021
Phase: Phase 1/Phase 2
Study type: Interventional

This is a first-in-human, Phase 1/2 open-label, multicenter, dose-escalation, safety, pharmacokinetics (PK), and biomarker study of CBX-12 in subjects with advanced or metastatic refractory solid tumors.

NCT ID: NCT04157322 Active, not recruiting - Clinical trials for Colorectal Cancer Metastatic

Plasma 5hmC Signatures as a Marker of Colorectal / Appendiceal Peritoneal Metastasis

Start date: August 26, 2019
Phase:
Study type: Observational

Patients with peritoneal metastasis of colorectal or high grade appendiceal origin who are candidates for cytoreductive surgery with HIPEC (hyperthermic intraperitoneal chemotherapy) will be enrolled in this study. Blood collection for measurements of plasma cell-free DNA hydroxymethylation signatures will be performed at different time points, before and after surgery, in order to determine if plasma hydroxymethylation signatures are more sensitive than conventional tumor markers in identifying clinically detectable recurrence at 1 year after surgery.

NCT ID: NCT03510923 Active, not recruiting - Cholecystectomy Clinical Trials

Selective Rather Than Routine Histopathological Examination Following Appendectomy and Cholecystectomy

FANCY
Start date: May 1, 2018
Phase:
Study type: Observational

The FANCY study will investigate whether a selective policy of histopathological examination of appendices and gallbladders based on the intraoperative findings of the surgeon is safe and cost-effective.

NCT ID: NCT02387203 Active, not recruiting - Clinical trials for Pseudomyxoma Peritonei

Antibiotic Treatment and Long-term Outcomes of Patients With Pseudomyxoma Peritonei of Appendiceal Origin

Start date: January 2015
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine the impact of antibiotic therapy on the disease progression and overall survival of patients with Pseudomyxoma Peritonei (PMP).

NCT ID: NCT01815359 Active, not recruiting - Colorectal Cancer Clinical Trials

ICARuS Post-operative Intraperitoneal Chemotherapy (EPIC) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) After Optimal Cytoreductive Surgery (CRS) for Neoplasms of the Appendix, Colon or Rectum With Isolated Peritoneal Metastasis

ICARuS
Start date: March 2013
Phase: Phase 2
Study type: Interventional

This is the first randomized trial comparing Early post-operative intraperitoneal chemotherapy (EPIC) and hyperthermic intraperitoneal chemotherapy (HIPEC) for appendiceal and colorectal cancer. The purpose of this study is to find out what effects, good and/or bad, EPIC and HIPEC after cytoreductive surgery have on the patient and the appendiceal, rectal or colon cancer.

NCT ID: NCT00006112 Active, not recruiting - Colorectal Cancer Clinical Trials

Fluorouracil With or Without Mitomycin in Treating Patients With Peritoneal Cancer

Start date: January 1996
Phase: Phase 2
Study type: Interventional

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Randomized phase II trial to compare the effectiveness of fluorouracil with or without mitomycin in treating patients who have peritoneal cancer.